Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
110 hedge funds and large institutions have $287M invested in Calithera Biosciences, Inc in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 50 increasing their positions, 15 reducing their positions, and 8 closing their positions.
375% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 8
233% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 15
38% more funds holding
Funds holding: 80 → 110 (+30)
35% more capital invested
Capital invested by funds: $212M → $287M (+$74.3M)
17% less call options, than puts
Call options by funds: $386K | Put options by funds: $467K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$13.4M |
| 2 |
BlackRock
New York
|
+$6.23M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.83M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$4.56M |
| 5 |
Primecap Management
Pasadena,
California
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$14.7M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$2.22M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$819K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$734K |
| 5 |
Renaissance Technologies
New York
|
-$326K |
CALA Hedge Fund Activity: Q2 2020 in Review
110 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2020, worth a combined $287M — up 35% from $212M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new CALA positions and 8 closed out — a net gain of 30 holders — while 50 added to existing stakes and 15 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $13.4M. The largest seller was BVF Inc, cutting an estimated $14.7M.
- 110 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2020, up from 80 in Q1 2020.
- Funds reported $287M of Calithera Biosciences, Inc stock for Q2 2020, up 35% quarter-over-quarter.
- 38 funds opened new Calithera Biosciences, Inc positions in Q2 2020 and 8 closed out, a net change of +30 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2020 was Great Point Partners, an estimated $13.4M added.
- The largest Calithera Biosciences, Inc seller in Q2 2020 was BVF Inc, an estimated $14.7M sold.
Based on aggregated 13F filings for Q2 2020.